Related by context. All words. (Click for frequent words.) 74 colorectal carcinoma 74 recurrent glioblastoma multiforme 74 biochemical relapse 73 urothelial carcinoma 73 relapsed MM 73 Papillary 73 prostate carcinoma 73 metastatic malignant 73 radiotherapy RT 72 histologic subtype 72 colorectal adenoma 72 papillary renal cell carcinoma 72 prostate cancer CaP 72 nodal metastasis 72 nonmetastatic 72 F FDG PET 72 leiomyomas 72 metastatic pancreatic 71 chemoradiation therapy 71 neoplasias 71 ductal carcinomas 71 radical prostatectomy RP 71 radical nephrectomy 71 liver resection 71 recurrent DVT 71 locoregional recurrence 71 HBeAg negative 71 pancreatic adenocarcinoma 71 underwent resection 71 interferon ribavirin 71 PSA nadir 70 Endometrial 70 unresectable tumors 70 FluCAM arm 70 total thyroidectomy 70 invasive carcinomas 70 Soft Tissue Sarcoma 70 adenomatous 70 hepatic metastases 70 thymoma 70 Naive Patients 70 morphometric vertebral fractures 70 basal cell carcinoma BCC 70 deep venous thromboses 70 biochemical recurrence 70 debulking surgery 70 Mitomycin C 70 pT3 70 SSc 70 Surgical resection 70 FOLFOX6 70 histological subtype 70 Doxil ® 70 transurethral resection 70 pulmonary metastasis 70 pegylated liposomal doxorubicin 70 pT2 70 B Cell Lymphoma 70 malignant ascites 70 CIN2 + 70 colorectal liver metastases 69 breast carcinoma 69 mucinous 69 metastatic neuroendocrine tumors 69 underwent surgical resection 69 LHRH receptor positive 69 leukemia AML 69 adrenalectomy 69 Follicular Lymphoma 69 urothelial cancer 69 peritoneal carcinomatosis 69 biliary tract cancer 69 Adjuvant chemotherapy 69 LV dysfunction 69 thyroid carcinoma 69 HER2 overexpression 69 anterior uveitis 69 resectable pancreatic cancer 69 immunohistochemical 69 metastatic gastric 69 recurrent metastatic 69 advanced adenoma 69 allogeneic hematopoietic stem cell 69 renal tumors 69 microsatellite instability 69 J Am Coll 69 stage IIIb IV 69 primary hyperparathyroidism 69 K ras mutations 69 acute aortic dissection 69 transthoracic 69 epithelial tumors 69 paraganglioma 69 bladder carcinoma 69 smoldering myeloma 69 Immunohistochemical staining 69 haematologic 69 Adenomas 69 metastatic lymph nodes 69 clinicopathological features 69 operable breast cancer 69 transvaginal sonography 69 myelodysplastic myeloproliferative diseases 69 peritoneal cancer 69 allogeneic HSCT 69 cytoreduction 69 histologically confirmed 69 fallopian tube carcinoma 69 epithelioid 69 leiomyoma 69 mycosis fungoides 69 Folfox 69 nonalcoholic steatohepatitis NASH 69 tipranavir ritonavir 69 advanced hepatocellular carcinoma 69 node metastases 69 endometrial carcinoma 68 lymphocytosis 68 hematological parameters 68 nondiabetic patients 68 undergone radical prostatectomy 68 metastatic GIST 68 adriamycin 68 pheochromocytoma 68 CYT# potent vascular disrupting 68 Subgroup analysis 68 Relapsed Refractory 68 bronchoalveolar lavage 68 metastatic renal 68 malignant neoplasm 68 intestinal metaplasia 68 breast carcinomas 68 acute myeloid 68 transarterial 68 chemoradiotherapy 68 mediastinitis 68 hematopoietic cancers 68 BCG refractory 68 metaplasia 68 nodal metastases 68 invasive candidiasis 68 liver metastasis 68 postoperative chemotherapy 68 PCa 68 situ CIS 68 ischemia driven 68 HBeAg 68 precursor lesions 68 Degarelix 68 lactate dehydrogenase LDH 68 clinicopathologic 68 pCR 68 intravesical therapy 68 Histological 68 % CI #.#-#.# [003] 68 CR nPR 68 neoadjuvant treatment 68 papillary thyroid carcinoma 68 elevated transaminases 68 HER2 expression 68 tumors GIST 68 Radical prostatectomy 68 tumor histology 68 cutaneous melanoma 68 chemoembolization 68 FUSILEV enhances 68 gastric adenocarcinoma 68 hepatorenal syndrome 68 resectable 68 postoperative AF 68 preoperative PSA 68 oral squamous cell 68 PSADT 68 arteriography 68 ertapenem 68 nicardipine 68 gemcitabine carboplatin 68 Histologic 68 caspofungin 68 papillary carcinoma 68 hamartomas 68 Percutaneous vertebroplasty 68 Adjunctive 68 histopathologic examination 68 pulmonary metastases 68 MGUS 68 ug dose 68 liposomal amphotericin B 68 ALT elevation 68 Breast conserving 68 wedge resection 68 metachronous 68 cancer mCRC 68 multivariate Cox 68 malignant lymphoma 68 genotypic resistance 68 Contralateral 68 Hormone Refractory Prostate Cancer 67 TNF blocker therapy 67 ErbB2 positive 67 distant metastasis 67 Patients Receiving 67 perioperatively 67 transplantation HCT 67 invasive aspergillosis 67 occlusive disease 67 nonmelanoma skin cancers 67 baseline LDH 67 T1c 67 adjuvant radiotherapy 67 HRCT 67 ASCUS 67 endometrial hyperplasia 67 confidence interval #.#-#.# 67 gadolinium enhanced 67 ER CHOP 67 tumor necrosis 67 ALA PDT 67 metastatic bladder 67 prostate cancer PCa 67 Thal Dex 67 hepatocellular carcinomas 67 TURBT 67 Acute Coronary Syndromes ACS 67 advanced adenomas 67 Partial Response 67 neoadjuvant 67 appendiceal 67 Kaplan Meier analysis 67 BRAF V#E mutation 67 lung esophageal 67 thrombocytopenic 67 polycythemia vera essential thrombocythemia 67 squamous cell carcinoma SCC 67 Peginterferon 67 CTEPH 67 parathyroid carcinoma 67 colorectal adenocarcinoma 67 rs# [004] 67 hormone receptor negative 67 FOLFIRI alone 67 renal cell carcinomas 67 surgically resected 67 mutated K ras 67 Refractory Hodgkin Lymphoma 67 anthracycline taxane 67 osteoid osteoma 67 CLL SLL 67 achieved CCyR 67 immunohistochemical staining 67 Cystectomy 67 paragangliomas 67 bronchogenic carcinoma 67 resistant hormone refractory 67 essential thrombocythemia ET 67 Flu Cy 67 Fludarabine 67 intrahepatic 67 somatostatin analog 67 hematological relapse 67 Myelodysplastic Syndrome MDS 67 basal cell skin 67 malignant pleural mesothelioma 67 GISTs 67 non resectable metastatic 67 concurrent chemoradiation 67 ischemic lesions 67 ductal adenocarcinoma 67 Natalizumab 67 sarcomatoid 67 Myelodysplastic Syndrome 67 thalidomide Thalomid 67 proctitis 67 PEG IFN 67 gemcitabine Gemzar 67 gefitinib Iressa 67 chemotherapy cisplatin 67 Asymptomatic 67 cytogenic 67 Diffuse Large B 67 Adjuvant therapy 67 postoperative complication 67 histologically proven 67 CIN3 67 carcinoid tumor 67 pamidronate 67 ribavirin RBV 67 Pemetrexed 67 Gastrointestinal Stromal Tumors 67 cisplatin gemcitabine 67 reflux esophagitis 67 pretransplant 67 benign nodules 67 oesophageal adenocarcinoma 67 diabetes mellitus DM 67 bacillus Calmette Guerin 67 hypophosphatemia 67 differentiated thyroid 67 FOLFOX4 67 hypervascular tumors 67 echocardiographic parameters 67 perioperative complications 67 cytoreductive surgery 67 oblimersen 67 keloid scarring 67 metastatic renal cell carcinoma 67 extramedullary 67 Arch Intern Med 67 contralateral breast 67 fibroma 67 liver histology 67 deletion 5q 67 Carcinomas 67 liver transplant recipients 67 relapsing remitting MS RRMS 67 intraoperative complications 67 invasive lobular carcinoma 67 ovarian carcinoma 67 mRCC 67 duplex ultrasonography 67 endoscopic ultrasonography 67 resected pancreatic cancer 67 HER2 positive metastatic breast 67 clinicopathological 67 Basal Cell 67 artery stenosis 67 rebleeding 66 STRIDE PD 66 transabdominal 66 unfractionated heparin UFH 66 gastrointestinal stromal tumors GIST 66 Pharmacokinetics PK 66 ALT normalization 66 carcinoma HCC 66 pathologic diagnosis 66 temozolomide TMZ 66 recurrent GBM 66 β blockers 66 antithymocyte globulin 66 lumbar disk herniation 66 esophageal carcinoma 66 ximelagatran 66 intravesical chemotherapy 66 treat benign prostatic 66 CC genotype 66 Sezary syndrome 66 Diabetic nephropathy 66 mutated KRAS 66 superficial femoral 66 Oral Fingolimod 66 Squamous 66 pleomorphic 66 stage IIIB 66 galiximab 66 Patency 66 metastatic malignant melanoma 66 idarubicin 66 KRAS mutations occur 66 androgen suppression 66 ^ sup #m 66 secondary hyperparathyroidism 66 murine model 66 macroalbuminuria 66 neurologic progression 66 pancreatic carcinoma 66 Neoadjuvant 66 Anaplastic 66 ritonavir boosted 66 MALT lymphoma 66 Multiple Myeloma MM 66 spiral computed tomography 66 abdominal computed tomography 66 polypoid 66 abacavir Ziagen 66 Hypotension 66 paroxysmal AF 66 external beam radiotherapy 66 cholelithiasis 66 TO AVOID PREGNANCY WHILE 66 fluorodeoxyglucose positron emission tomography 66 overt nephropathy 66 esophageal gastric 66 placebo dexamethasone 66 epithelial ovarian 66 cystoscopic 66 allograft rejection 66 Platinol ® 66 supratentorial 66 Lymphocytic 66 HeFH 66 carcinoembryonic antigen 66 esophagogastric 66 malignant neoplasms 66 KRAS wild 66 refractory chronic lymphocytic 66 Acute myeloid leukemia 66 leukemia CLL 66 skeletal metastases 66 alkylating agent 66 Renal Cell Carcinoma 66 postintervention 66 Lenalidomide 66 esophageal resection 66 situ LCIS 66 thyroglobulin 66 invasive lobular 66 Metastases 66 Stomatitis 66 thymectomy 66 micafungin 66 Coronary Artery Bypass Graft 66 ipsilateral breast 66 fallopian tube cancers 66 cervical lymph nodes 66 ST Segment Elevation 66 oral clodronate 66 Gorlin syndrome 66 transurethral 66 #F FDG PET 66 Mantle Cell Lymphoma 66 invasive ductal 66 micrometastases 66 nephrectomy 66 gastroduodenal 66 idiopathic membranous nephropathy 66 pleurodesis 66 coronary stenosis 66 pulmonary alveolar 66 androgen ablation 66 undergoing radical cystectomy 66 surgically resectable 66 histopathologic findings 66 curative resection 66 complement inhibitor eculizumab 66 comparator arm 66 nephron sparing surgery 66 benign prostatic hyperplasia enlarged 66 ascending aortic 66 extracranial 66 #Gy 66 mucosal inflammation 66 BRAF V#E 66 lumbar disc herniation 66 de novo AML 66 HER2 amplification 66 HIV HCV coinfected 66 dysuria 66 Atypical Hemolytic Uremic Syndrome 66 serous ovarian cancer 66 radical cystectomy 66 5-FU/LV 66 LVNC 66 Chronic Prostatitis 66 Peginterferon Alfa 2a 66 hepatocellular cancer 66 autologous SCT 66 gastric carcinoma 66 VFEND 66 cutaneous squamous cell carcinoma 66 Circulating tumor cells 66 trastuzumab Herceptin ® 66 ultrasonographic 66 alpha1 antitrypsin deficiency 66 neoadjuvant therapy 66 hepatic resection 66 extracapsular extension 66 lung metastasis 66 Glioblastoma Multiforme 66 ABVD 66 Renal Cell Carcinoma RCC 66 patients undergoing CABG 66 Sentinel node biopsy 66 azacytidine 66 idiopathic PAH 66 Pegylated Interferon 66 Anthracycline 66 hemodynamically significant 66 lichen planus 66 Index CDAI 66 smoldering multiple myeloma 66 #.#ng/ml 66 clinically localized prostate 66 mL/min/#.# m 2 66 radioiodine therapy 66 subtrochanteric 66 recurrent malignant glioma 66 atypical hyperplasia 66 intraepithelial neoplasia 66 drug eluting stent implantation 66 gemcitabine Gemzar ® 66 CR CRu 66 Venous thromboembolism 66 hip BMD 66 pelvic lymphadenectomy 66 HGPIN 66 locoregional 66 Renal Artery 66 CHOP chemotherapy 66 Pegylated Liposomal Doxorubicin 66 neutropenic sepsis 66 ANCA associated 66 Fine needle aspiration 66 metastatic colorectal 66 pretreatment serum 66 dysplastic nevi 66 relapsed Acute Myeloid 66 allogeneic bone marrow 66 adjunctive placebo 66 HNSCC 66 5FU 66 angiographically 66 urine cytology 66 osteochondroma 66 Microalbuminuria 66 Leukemias 66 asymptomatic carotid stenosis 66 androgen deprivation 66 % CI #.#-#.# [007] 66 vincristine doxorubicin 66 minimally symptomatic 66 Irinotecan 66 lobular carcinoma 66 HBeAg negative patients 66 immunostaining 66 hypercalciuria 65 cTnI 65 Intravenous immunoglobulin 65 INCB# [003] 65 gastroesophageal junction 65 chemoresistant 65 hepatocellular carcinoma HCC 65 colorectal metastases 65 ara C 65 malignant fibrous histiocytoma 65 ABCB1 65 PLX STROKE targeting 65 kidney urologic 65 cytoreductive nephrectomy 65 bullous 65 Castration Resistant Prostate Cancer 65 gastric cardia 65 PAOD 65 invasive bladder 65 antiretroviral naïve 65 pheochromocytomas 65 TNF Tumor Necrosis Factor 65 receiving VELCADE 65 detrusor overactivity 65 superficial bladder cancer 65 ß blockers 65 Surgical excision 65 specific antigen PSA 65 stratifying patients 65 pancreatectomy 65 Adjuvant Chemotherapy 65 endobronchial 65 neoplasm 65 lymphoid malignancies 65 CIMZIA TM certolizumab pegol 65 elevated IOP 65 hyperplastic 65 systemic amyloidosis 65 atrophic gastritis 65 preintervention 65 cisplatin chemotherapy 65 metastatic hormone refractory 65 castrate resistant 65 cholangiocarcinoma 65 noninvasive outpatient 65 EGFR HER2 65 completely resected 65 Fulvestrant 65 recurrent NSCLC 65 transrectal ultrasound guided 65 familial amyloidotic polyneuropathy FAP 65 NSTE ACS 65 advanced neoplasia 65 KRAS status 65 RENAL 65 lymphoproliferative disorders 65 localized renal 65 Vidaza ® 65 postoperative morbidity 65 conjunctival hyperemia 65 refractory cutaneous T 65 metastatic colorectal carcinoma 65 elevated serum creatinine 65 erlotinib Tarceva ® 65 preoperative chemotherapy 65 alanine aminotransferase ALT 65 percutaneous vertebroplasty 65 subependymal giant cell 65 aortic root replacement 65 lung metastases 65 neutropaenia 65 estramustine 65 antiangiogenic therapy 65 adjuvant radiation 65 CIMZIA ™ 65 Acute Myeloid Leukaemia AML 65 percutaneous transluminal coronary angioplasty 65 Ribavirin causes 65 refractory NSCLC 65 thromboembolic complications 65 #mg BID [001] 65 seminoma 65 nonischemic 65 colorectal neoplasms 65 rFSH 65 Ischemic 65 mitoxantrone plus 65 cerebral vasospasm 65 detectable HCV RNA 65 bladder ovarian 65 squamous histology 65 Hurthle cell 65 radical retropubic prostatectomy 65 dasatinib Sprycel 65 intrathoracic 65 aplastic anemia AA 65 oral Hycamtin 65 bone scintigraphy 65 prospective multicenter study 65 % CI #.#-#.# [008] 65 retroperitoneal 65 lymphovascular invasion 65 obstructive coronary artery 65 cervical intraepithelial neoplasia 65 cytogenetic abnormalities 65 univariate 65 erythema nodosum 65 prostate adenocarcinoma 65 urolithiasis 65 cartilage lesions 65 colon carcinoma 65 T1a 65 Adjuvant Treatment 65 cytokeratin 65 Intracoronary 65 intravenous bisphosphonates 65 Carcinoma 65 squamous cell lung cancer 65 Nebulized 65 TACE 65 CP CPPS 65 histologic findings 65 elevated LDH 65 VELCADE melphalan 65 thetreatment 65 variceal bleeding 65 prostate TURP 65 affective psychosis 65 osteosarcomas 65 artery embolization 65 Cardiopulmonary bypass 65 hemodynamically unstable 65 amisulpride 65 malignant lesions 65 Prognostic significance 65 hydronephrosis 65 sensory neuropathy 65 RRM1 65 Hazard Ratio 65 p = NS 65 spontaneous bacterial peritonitis 65 intestinal polyps 65 nonfatal MI 65 urothelial 65 Postoperative complications 65 needle aspiration 65 Prostatic 65 thyroid nodules 65 pericardial effusion 65 lactate dehydrogenase 65 thromboembolism 65 LV ejection fraction 65 spinal metastases 65 thyrotoxicosis 65 iodixanol 65 cardiac magnetic resonance 65 vitreous floaters 65 ductal cancer 65 % Confidence Interval 65 recurrent glioblastoma 65 transitional cell carcinoma 65 intra arterial 65 refractory Hodgkin 65 cisplatin resistant 65 FDG uptake 65 abacavir lamivudine 65 hyperacute 65 Lymph node 65 EGFR mutation positive 65 follicular lymphomas 65 lesional 65 posttreatment 65 PEGylated anti 65 CTAP# Capsules 65 clodronate 65 serum aminotransferase levels 65 5-fluorouracil/leucovorin 65 dacarbazine DTIC 65 neoplastic 65 leukemia APL 65 squamous 65 lymphocytic 65 intact parathyroid hormone 65 undetectable HBV DNA 65 ductal breast cancer 65 GSTP1 65 osteoporotic compression fractures 65 pulmonary artery banding 65 QTcF 65 Hodgkin lymphoma HL 65 relapsed AML 65 scleral buckling 65 micrometastasis 65 paricalcitol 65 thrombocytosis 65 tipranavir r 65 choriocarcinoma 65 Relapsing remitting MS 65 atypical ductal hyperplasia 65 Chronic lymphocytic leukemia 65 partial remissions 65 squamous intraepithelial lesions 65 Glioma 65 gene polymorphism 65 thoracoscopic lobectomy 65 progression TTP 65 Xelox 65 anaplastic astrocytoma AA 65 hepatic arterial 65 GOUT 65 extrapleural pneumonectomy 65 tolterodine ER 65 refractory ischemia 65 cystoid macular edema 65 femoral neck fracture 65 cyclophosphamide methotrexate 65 BARACLUDE ® 65 HBeAg positive patients 65 K#N 65 Invasive Breast Cancer 65 aminotransferase levels 65 urethral stricture 65 Antitumor Activity 65 sonographically 65 neoadjuvant chemotherapy 65 tumor lysis syndrome 65 medically inoperable 65 Computed tomographic 65 prostate cancer HRPC 65 DOXIL 65 precancerous condition 65 Chronic Lymphocytic Leukemia CLL 65 osteoporotic vertebral compression fractures 65 Randomized Study 65 polyposis 65 #F FDG 65 hormone refractory metastatic prostate 65 Toxicities 65 gemcitabine cisplatin 65 Complicated Skin 65 Decitabine 65 Acute Myelogenous Leukemia AML 65 Nilotinib 65 Catheter Associated 65 immunomodulatory therapy 65 J Am Soc 65 vertebral fracture 65 Stage IIB 65 Duodenal 65 EBRT 65 HLA DRB1 * 65 T2 lesion volume 65 titrated glipizide 65 submandibular gland 65 antiandrogens 65 CI #.#-#.# [001] 65 Cell Lymphoma 65 biologic DMARD 65 calculi 65 mesangial 65 colorectal carcinomas 65 bronchioloalveolar carcinoma 65 symptomatic VTE 65 cirrhotic 65 mitomycin C 65 HBeAg seroconversion 65 transcranial Doppler ultrasound 65 TRUS 65 moderate renal impairment 65 elective PCI 65 F FLT 65 postoperative radiotherapy 65 #:#-# [031] 65 Cholangiocarcinoma 65 PegIFN RBV 65 hepatectomy 65 benign neoplasms 65 urothelial bladder cancer 65 syngeneic 65 PRADAXA #mg 65 Langerhans cell histiocytosis 65 Acute Renal Failure 65 neutropenia dehydration dyspnea 65 grade squamous intraepithelial 64 TMP SMX 64 thromboembolic events 64 pulmonary angiography 64 prognostic indicator 64 carotid stenosis 64 non valvular atrial 64 â ‰ ¥ 64 surgical revascularization 64 severe oral mucositis 64 small lymphocytic lymphoma 64 vWD 64 sorafenib Nexavar 64 adenomatous polyps 64 recurrent venous thromboembolism 64 KRAS mutation 64 Prognostic factors 64 tumor xenograft models 64 retrospective cohort 64 Cystatin C 64 epirubicin cyclophosphamide 64 Menopausal hormone therapy 64 NSTEMI 64 Patients Treated With 64 symptomatic intracranial 64 CMV infections 64 Leydig cell 64 stable angina pectoris 64 anti JCV antibodies 64 pain palliation 64 Thromboembolism 64 adenoma recurrence 64 osteoporotic vertebral fractures 64 Helicobacter pylori eradication 64 premalignant lesions 64 flutamide 64 Postoperatively 64 HIV coinfected 64 Posaconazole 64 infliximab monotherapy 64 BCG refractory carcinoma 64 Carotid Revascularization Endarterectomy vs. 64 Philadelphia Chromosome Positive 64 ribavirin therapy 64 multivariate analyzes 64 Angiographic 64 OPCAB 64 overactive bladder syndrome 64 Subarachnoid hemorrhage 64 Intravitreal 64 precancerous cervical 64 G CSFs 64 osteopenic 64 varicocele 64 Peginterferon alfa 2b 64 mcg QD 64 superficial basal cell carcinoma 64 myocardial viability 64 RECORD1 64 metastatic bone 64 nonvertebral fracture 64 postmenopausal osteoporotic women 64 recurrent VTE 64 splenic 64 immunohistochemical analysis 64 lymph node metastasis 64 sulfasalazine 64 T2DM 64 Neoplasms 64 invasive carcinoma 64 ZACTIMA 64 IFN beta 64 variceal hemorrhage 64 systemic anaplastic large 64 novel VDA molecule 64 myocardial infarction ventricular fibrillation 64 SLNB 64 etiologic 64 Am J Cardiol 64 paclitaxel carboplatin 64 ® lenalidomide 64 catheter occlusion 64 antigen PSA levels 64 malignant polyps 64 assessing T DM1 64 lumbar spine BMD 64 renal artery stenting 64 QTc prolongation 64 choroidal neovascularization 64 histopathological 64 interstitial brachytherapy 64 cis retinoic acid 64 orthotopic 64 rFVIIa 64 Cutaneous T 64 Introgen ADVEXIN 64 ZOLINZA 64 plain radiographs 64 MGd 64 Hematologic 64 imatinib therapy 64 immune thrombocytopenic purpura 64 glomerular filtration 64 Carotid artery 64 Histopathologic 64 Estrogen Receptor 64 Relapsing Remitting Multiple Sclerosis 64 aortic coarctation 64 metastatic lesions 64 Medullary thyroid cancer 64 radiochemotherapy 64 pancreatic resection 64 Paraplatin ® 64 refractory AML 64 Metastatic 64 NNRTI resistance 64 renal pelvis 64 cranial irradiation 64 calcineurin inhibitor 64 JMML 64 ischemic mitral regurgitation 64 bisoprolol 64 diagnosing coronary artery 64 TAXUS Express Stent 64 bronchoalveolar 64 sorafenib tablets 64 prognostic variables 64 RAS mutations 64 Histologically 64 cervical carcinoma 64 pulmonary artery hypertension 64 myeloproliferative disorder 64 ibritumomab tiuxetan 64 cytologic 64 upper endoscopy 64 interferon alfa 2a 64 Response Evaluation Criteria 64 Fluorouracil 64 5 FU leucovorin 64 perioperative mortality 64 achieved ACR# 64 serum prostate 64 Parathyroid Hormone 64 adenoidectomy 64 FDG-PET/CT 64 unresectable stage 64 varices 64 osteolytic 64 agalsidase alfa 64 Tumor Response 64 Ejection Fraction 64 octreotide LAR 64 Prostatitis 64 receiving VICTRELIS 64 Stage IIIb 64 transthoracic echocardiography 64 rituximab Rituxan 64 bilateral oophorectomy 64 aromatase inhibitor therapy 64 immunocompetent 64 Allogeneic 64 unstable angina pectoris 64 Chronic HCV 64 TRAIL R1 64 Recurrence 64 paresthesias 64 Prostate Cancer Progression 64 ADPKD 64 intima media thickness 64 renal biopsy 64 microbiological eradication 64 adjuvant tamoxifen 64 Advanced Renal Cell 64 dysplastic lesions 64 #mg QD [002] 64 Tyrosine Kinase Inhibitor 64 arteritis 64 Hepatocellular Carcinoma HCC 64 acute coronary syndromes ACS 64 thromboembolic disease 64 histologic examination 64 nucleoside naive 64 EGFR TKI 64 Navelbine 64 gastric corpus 64 treatment naive genotype 64 conventional coronary angiography 64 atrophic vaginitis 64 pathologic examination 64 Platinol ® cisplatin 64 multivariate logistic regression 64 catheter angiography